Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial
Afshani, Seyyedeh Maryam, Mirhassani, Reihaneh, Hosseini, Hamed, Hosseini, Reihaneh, Tehranian, Afsaneh, Malekzadeh, Reza, Ostovar, Afshin, Abdolghaffari, Amir Hossein, Ghobadi, Mohammad Amin, Hedayatjoo, Behnaz, Hazegh Fetratjoo, Delara, Rezagholi, Zahra, Anari, AmirHossein, Moini, Ashraf
Published in European journal of cancer prevention (01.11.2022)
Published in European journal of cancer prevention (01.11.2022)
Get more information
Journal Article
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate‐to‐severe glabellar lines: A non‐inferiority double blinded randomized controlled trial
Afshani, Seyyedeh Maryam, Samadi, Aniseh, Ayatollahi, Azin, Kashani, Mansour Nassiri, Ahmad Nasdrollahi, Saman, Hosseini, Hamed, Rezagholi, Zahra, Hedayatjoo, Behnaz, Hazegh Fetratjoo, Delara, Ghobadi, Mohammad Amin, Anari, AmirHossein, Saeedifar, Sajjad, Firooz, Alireza
Published in Journal of cosmetic dermatology (01.06.2022)
Published in Journal of cosmetic dermatology (01.06.2022)
Get full text
Journal Article